|
1
|
Hamzah H, Nuryastuti T, Rahmah W, Chabib L, Syamsul ES, Lestari D, Jabbar A, Tunjung Pratiwi SU. Molecular Docking Study of the C-10 Massoia Lactone Compound as an Antimicrobial and Antibiofilm Agent against Candida tropicalis. ScientificWorldJournal 2023; 2023:6697124. [PMID: 37766863 PMCID: PMC10522437 DOI: 10.1155/2023/6697124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2023] [Revised: 08/14/2023] [Accepted: 08/26/2023] [Indexed: 09/29/2023] Open
Abstract
Antimicrobial resistance is now considered a global health problem because it reduces the effectiveness of antimicrobial drugs. According to the World Health Organization (WHO), the highest mortality rate is associated with infections caused by multidrug-resistant microorganisms, with approximately 700,000 deaths worldwide each year. The aim of this study was to determine the potential of C-10 massoia lactone to inhibit the growth of fungi and C. tropicalis biofilm, and molecular docking studies were performed to determine the nature of the inhibition. The study was conducted using the microdilution method for antifungal and antibiofilm testing and designed with a molecular docking approach. Furthermore, an analysis using the scanning electron microscope (SEM) was performed to evaluate the mechanism of effect. The results obtained showed that C-10 massoia lactone can inhibit the growth of fungi by 84.21% w/v. Meanwhile, the growth of C. tropicalis biofilm in the intermediate phase was 80.23% w/v and in the mature phase was 74.23% w/v. SEM results showed that C-10 massoia lactone damaged the EPS matrix of C. tropicalis so that hyphal formation was hindered due to damage to fungal cells, resulting in a decrease in attachment, density, and lysis of C. tropicalis fungal cells. Based on molecular docking tests, C-10 massoia lactone was able to inhibit biofilm formation without affecting microbial growth, while docking C-10 massoia lactone showed a significant binding and has the potential as an antifungal agent. In conclusion, the C-10 massoia lactone compound has the potential as an antibiofilm against C. tropicalis, so it can become a new antibiofilm agent.
Collapse
Affiliation(s)
- Hasyrul Hamzah
- Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia
- Faculty of Pharmacy, Universitas Muhammadiyah Kalimantan Timur, Samarinda, Kalimantan Timur 75124, Indonesia
- Indonesian Biofilm Research Collaboration Centre (IBRCC), Farmako Street, Sekip Utara, Yogyakarta 55281, Indonesia
| | - Titik Nuryastuti
- Indonesian Biofilm Research Collaboration Centre (IBRCC), Farmako Street, Sekip Utara, Yogyakarta 55281, Indonesia
- Department of Microbiology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Farmako Street, North Sekip, Yogyakarta 55281, Indonesia
| | - Widya Rahmah
- Indonesian Biofilm Research Collaboration Centre (IBRCC), Farmako Street, Sekip Utara, Yogyakarta 55281, Indonesia
- Department of Microbiology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Farmako Street, North Sekip, Yogyakarta 55281, Indonesia
| | - Lutfi Chabib
- Department of Pharmacy, Islamic University of Indonesia, Yogyakarta, Indonesia
| | - Eka Siswanto Syamsul
- Department of Pharmacy, Sekolah Tinggi Ilmu Kesehatan Samarinda, Samarinda, East Borneo, Indonesia
| | - Dwi Lestari
- Faculty of Pharmacy, Universitas Muhammadiyah Kalimantan Timur, Samarinda, Kalimantan Timur 75124, Indonesia
| | - Asriullah Jabbar
- Indonesian Biofilm Research Collaboration Centre (IBRCC), Farmako Street, Sekip Utara, Yogyakarta 55281, Indonesia
- Department of Pharmacy, Faculty of Pharmacy, Haluoleo University, Kendari 93232, Indonesia
| | - Sylvia Utami Tunjung Pratiwi
- Indonesian Biofilm Research Collaboration Centre (IBRCC), Farmako Street, Sekip Utara, Yogyakarta 55281, Indonesia
- Faculty of Pharmacy, Universitas Gadjah Mada, North Sekip, Yogyakarta 55281, Indonesia
| |
Collapse
|
|
2
|
Peterfalvi A, Miko E, Nagy T, Reger B, Simon D, Miseta A, Czéh B, Szereday L. Much More Than a Pleasant Scent: A Review on Essential Oils Supporting the Immune System. Molecules 2019; 24:E4530. [PMID: 31835699 PMCID: PMC6943609 DOI: 10.3390/molecules24244530] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2019] [Revised: 12/03/2019] [Accepted: 12/07/2019] [Indexed: 12/14/2022] Open
Abstract
The augmenting acceptance and application of herbal medicine in prevention and treatment of diseases also involve the use of plant essential oils (EOs) through different routes of administration (aromatherapy). Scientific data supporting the efficacy of certain herbal products are continuously growing; however, the cumulative evidence is not always sufficient. The anti-inflammatory properties of EOs have been investigated more extensively and also reviewed in different settings, but so far, our review is the first to summarize the immune-supporting properties of EOs. Our aim here is to synthesize the currently available data on the immune function enhancing effects of EOs. An online search was conducted in the PubMed database, which was terminated at the end of July 2019. Other articles were found in the reference lists of the preselected papers. Studies that applied whole EOs with known components, or single EO constituents under in vitro or in vivo laboratory conditions, or in human studies, and de facto measured parameters related to immune function as outcome measures were included. Two specific fields, EO dietary supplementation for livestock and fish, and forest bathing are also explored. Some EOs, particularly eucalyptus and ginger, seem to have immune function enhancing properties in multiple studies.
Collapse
Affiliation(s)
- Agnes Peterfalvi
- Department of Laboratory Medicine, Medical School, University of Pecs, Ifjusag utja 13., 7624 Pecs, Hungary; (T.N.); (B.R.); (A.M.); (B.C.)
- Neurobiology of Stress Research Group, Szentagothai Research Centre, University of Pecs, Ifjusag utja 20., 7624 Pecs, Hungary
| | - Eva Miko
- Department of Medical Microbiology and Immunology, Medical School, University of Pecs, Szigeti ut 12., 7624 Pecs, Hungary; (E.M.); (L.S.)
| | - Tamas Nagy
- Department of Laboratory Medicine, Medical School, University of Pecs, Ifjusag utja 13., 7624 Pecs, Hungary; (T.N.); (B.R.); (A.M.); (B.C.)
| | - Barbara Reger
- Department of Laboratory Medicine, Medical School, University of Pecs, Ifjusag utja 13., 7624 Pecs, Hungary; (T.N.); (B.R.); (A.M.); (B.C.)
| | - Diana Simon
- Department of Immunology and Biotechnology, Medical School, University of Pecs, Szigeti ut 12., 7624 Pecs, Hungary;
| | - Attila Miseta
- Department of Laboratory Medicine, Medical School, University of Pecs, Ifjusag utja 13., 7624 Pecs, Hungary; (T.N.); (B.R.); (A.M.); (B.C.)
| | - Boldizsár Czéh
- Department of Laboratory Medicine, Medical School, University of Pecs, Ifjusag utja 13., 7624 Pecs, Hungary; (T.N.); (B.R.); (A.M.); (B.C.)
- Neurobiology of Stress Research Group, Szentagothai Research Centre, University of Pecs, Ifjusag utja 20., 7624 Pecs, Hungary
| | - Laszlo Szereday
- Department of Medical Microbiology and Immunology, Medical School, University of Pecs, Szigeti ut 12., 7624 Pecs, Hungary; (E.M.); (L.S.)
| |
Collapse
|